CN113201593B - Primer probe combination product for detecting ACTN3 genotype - Google Patents
Primer probe combination product for detecting ACTN3 genotype Download PDFInfo
- Publication number
- CN113201593B CN113201593B CN202110568459.1A CN202110568459A CN113201593B CN 113201593 B CN113201593 B CN 113201593B CN 202110568459 A CN202110568459 A CN 202110568459A CN 113201593 B CN113201593 B CN 113201593B
- Authority
- CN
- China
- Prior art keywords
- primer
- probe
- group
- reaction
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 125
- 239000013066 combination product Substances 0.000 title claims abstract description 15
- 229940127555 combination product Drugs 0.000 title claims abstract description 15
- 102100032956 Alpha-actinin-3 Human genes 0.000 title abstract description 23
- 101000797292 Homo sapiens Alpha-actinin-3 Proteins 0.000 title abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 108090000731 ribonuclease HII Proteins 0.000 claims description 21
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 230000003321 amplification Effects 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 238000011901 isothermal amplification Methods 0.000 claims description 11
- 239000006166 lysate Substances 0.000 claims description 7
- 101150042778 ACTN3 gene Proteins 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 5
- 108091028664 Ribonucleotide Proteins 0.000 claims description 5
- 239000002336 ribonucleotide Substances 0.000 claims description 5
- 125000002652 ribonucleotide group Chemical group 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 2
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 33
- 108020004414 DNA Proteins 0.000 description 23
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 12
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 10
- 102000039446 nucleic acids Human genes 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 125000006850 spacer group Chemical group 0.000 description 8
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 5
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 5
- 229960005156 digoxin Drugs 0.000 description 5
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- -1 aqua phoor 593 Chemical compound 0.000 description 4
- 239000002360 explosive Substances 0.000 description 4
- 238000003205 genotyping method Methods 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- 101710115089 Alpha-actinin-3 Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- KHQCCEUMCUSZKM-KVQBGUIXSA-N (2r,3s,5r)-5-(6,8-diaminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol Chemical compound NC1=NC2=C(N)N=CN=C2N1[C@H]1C[C@H](O)[C@@H](CO)O1 KHQCCEUMCUSZKM-KVQBGUIXSA-N 0.000 description 1
- RVWUFECBVNXJEN-YGOYTEALSA-N 1-[(2s,4s,5r)-4-hydroxy-5-(hydroxymethyl)-2-prop-1-ynyloxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@@]1(C#CC)C[C@H](O)[C@@H](CO)O1 RVWUFECBVNXJEN-YGOYTEALSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- XSGZNYKZSOJIAM-XUOJEKSQSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;2-(10h-phenoxazin-1-yl)ethanamine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1.O1C2=CC=CC=C2NC2=C1C=CC=C2CCN XSGZNYKZSOJIAM-XUOJEKSQSA-N 0.000 description 1
- MSHADEGKNJRMIU-YGOYTEALSA-N 4-amino-1-[(2s,4s,5r)-4-hydroxy-5-(hydroxymethyl)-2-prop-1-ynyloxolan-2-yl]pyrimidin-2-one Chemical compound C1=CC(N)=NC(=O)N1[C@@]1(C#CC)C[C@H](O)[C@@H](CO)O1 MSHADEGKNJRMIU-YGOYTEALSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- WNDDWSAHNYBXKY-UHFFFAOYSA-N ATTO 425-2 Chemical compound CC1CC(C)(C)N(CCCC(O)=O)C2=C1C=C1C=C(C(=O)OCC)C(=O)OC1=C2 WNDDWSAHNYBXKY-UHFFFAOYSA-N 0.000 description 1
- PWZJEXGKUHVUFP-UHFFFAOYSA-N ATTO 590 meta-isomer Chemical compound [O-]Cl(=O)(=O)=O.C1=2C=C3C(C)=CC(C)(C)N(CC)C3=CC=2OC2=CC3=[N+](CC)C(C)(C)C=C(C)C3=CC2=C1C1=CC=C(C(O)=O)C=C1C(O)=O PWZJEXGKUHVUFP-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101150092509 Actn gene Proteins 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- JFVJZFMWJVSZNC-KVQBGUIXSA-N [[(2r,3s,5r)-5-(2,6-diaminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 JFVJZFMWJVSZNC-KVQBGUIXSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 description 1
- GJVFBWCTGUSGDD-UHFFFAOYSA-L pentamethonium bromide Chemical compound [Br-].[Br-].C[N+](C)(C)CCCCC[N+](C)(C)C GJVFBWCTGUSGDD-UHFFFAOYSA-L 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009192 sprinting Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of molecular biology, in particular to a primer probe combination product for ACTN3 genotype detection. The primer probe combination product comprises an outer primer pair consisting of F3 and B3, an inner primer pair consisting of FIP and BIP, and a loop primer and a probe. The kit provided by the invention is used for detecting the ACTN3 genotype, has the characteristics of simplicity and rapidness in operation, provides an effective technical means for rapid detection of the ACTN3 genotype, and has important significance.
Description
Technical Field
The invention relates to the field of molecular biology, in particular to a primer probe combination product for ACTN3 genotype detection.
Background
The ACTN3 gene is a well-studied sports gene, and is considered to be a gene related to explosive sports such as sprinting and weightlifting for athletes in the olympic games and the top-grade sports, which are found by statistics of athletes, wherein the ACTN3 gene carries a much higher proportion than the high-level endurance athletes. The ACTN3 gene encodes alpha-actin (alpha-actinin-3), a protein that plays a structural role in skeletal muscle and plays a role in the process of muscle contraction.
rs1815739 is a common genetic variation on the gene, and a single base on the 16 th exon of the gene changes from C to T, so that 577 th amino acid is converted from arginine to a stop codon, and the synthesis of functional alpha-actinin-3 protein is prevented. Different genotypes differ significantly in athletic ability. The CC muscle performance is good, and the explosive force is strong, is fit for making the sprint person. CT type composite muscles, which generally have explosive force, may be suitable for sprint runners. The TT-type muscle has weak explosive force and strong endurance, and is suitable for long-distance runners.
Genotyping is carried out on rs1815739, so that the athlete can be guided to select and pull out better, the waste of resources is reduced, and the best performance is obtained. The rs1815739 is quickly typed, so that on one hand, the rapid selection of athletes is facilitated, the construction of sports industry in China is recommended, and on the other hand, the effect of better guiding movement can be achieved for common citizens, and the improvement of the health of the citizens is facilitated.
Conventional SNP typing techniques, including AS-PCR, taqman probe method, sanger sequencing, mass spectrometry, etc., none of which requires no complicated instrument, so that SNP typing must be performed in a conditional central laboratory, greatly limiting the application of the techniques. The isothermal amplification technology has lower requirements on equipment, but the conventional isothermal amplification technology has poor differentiating effect on single base and is not suitable for SNP detection.
In view of this, the present invention has been made.
Disclosure of Invention
The first aspect of the present invention relates to a primer probe combination product comprising an outer primer pair consisting of F3 and B3 and an inner primer pair consisting of FIP and BIP, as well as a loop primer and a probe;
the nucleotide sequences of F3, B3, FIP and BIP are shown in SEQ ID NO: 1-4;
the nucleotide sequence of the loop primer is shown in SEQ ID NO: 5-6;
the nucleotide sequence of the probe is shown in SEQ ID NO: 7-8, wherein 8 th and 9 th nucleotides at the 5' ends of the two probes are ribonucleotides.
The second aspect of the invention relates to a kit comprising a primer probe combination product as described above.
The third aspect of the invention relates to the use of a primer probe combination product as described above for the preparation of a reagent or kit for the genotyping of ACTN 3.
Compared with the prior art, the invention has the beneficial effects that:
1) The kit provided by the invention is used for detecting the ACTN3 genotype, has the characteristics of simplicity and rapidness in operation, provides an effective technical means for rapid detection of the ACTN3 genotype, and has important significance.
2) The kit provided by the invention adopts a ribonuclease HII report system to synchronously react with isothermal amplification, can realize effective amplification and detection of target genes at 55-65 ℃, and does not need temperature change or complex instruments. The reaction time is short, the reaction can be completed within 10-40min, and the detection result is accurate and specific.
3) In the method, ribonuclease HII has high specificity to the probe and the target sequence, and only the amplified product and the probe sequence are completely complementary to the probe can be cut off, so that a report signal is generated, the identification effect on single base change is better than that of other primer-based identification methods, and the specificity and accuracy of the result are greatly improved.
4) The reaction conditions required by detection are simple, the requirements on hardware are low, the cost is low, the method has no harm to the subjects, and the method is favorable for wide popularization of the technology.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are needed in the description of the embodiments or the prior art will be briefly described, and it is obvious that the drawings in the description below are some embodiments of the present invention, and other drawings can be obtained according to the drawings without inventive effort for a person skilled in the art.
FIG. 1 shows the results of verification of different probes in one embodiment of the invention;
FIG. 2 shows the detection result of a real sample according to an embodiment of the present invention;
FIG. 3 shows the stability test results of a cartridge according to one embodiment of the present invention;
FIG. 4 shows the results reported using a colloidal gold immunochromatographic card according to an embodiment of the present invention.
Detailed Description
Reference now will be made in detail to embodiments of the invention, one or more examples of which are described below. Each example is provided by way of explanation, not limitation, of the invention. Indeed, it will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the scope or spirit of the invention. For example, features illustrated or described as part of one embodiment can be used on another embodiment to yield still a further embodiment.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The term "and/or" as used herein includes any and all combinations of one or more of the associated listed items.
The invention relates to a primer probe combination product, which comprises an outer primer pair consisting of F3 and B3, an inner primer pair consisting of FIP and BIP, and a loop primer and a probe;
the nucleotide sequences of F3, B3, FIP and BIP are shown in SEQ ID NO: 1-4;
the nucleotide sequence of the loop primer is shown in SEQ ID NO: 5-6;
the nucleotide sequence of the probe is shown in SEQ ID NO: 7-8, wherein the 8 th nucleotide and the 9 th nucleotide of the 5' end of each probe are ribonucleotides.
FIP is a primer generated in such a way that it has an F2 region complementary to the F2c region of the target sequence at the 3-terminus and a sequence identical to the F1c region of the target gene at the 5-terminus.
F3 is a primer generated in such a manner that it has an F3 region complementary to the F3c region of the target gene.
BIP is a primer generated in such a way that it has a B2 region complementary to the B2c region of a target sequence at the 3 'end and a sequence identical to the Blc region of a target gene at the 5' end.
B3 is a primer generated in such a manner that it has a B3 region which is complementary to the B3c region of the target gene.
When the primer set of the present invention is used, one or two kinds of circular primers (LF primers or LB primers) may be added in order to accelerate the nucleic acid amplification reaction. Such a circular primer is designed so as to anneal to a region between F1 and F2 or a region between B1 and B2, and then added to the LAMP reaction system. In this way, these primers bind to loop portions that are not used in the nucleic acid amplification process, so that the nucleic acid reaction is promoted using all loop portions as the origin, thereby accelerating the nucleic acid amplification reaction.
The primer probe combination product can be matched with ribonuclease HII to realize more sensitive and specific diagnosis of ACTN3 genotype.
Ribonuclease HII (RNase HII) is an endonuclease suitable for nicking the 5' -end of ribonucleic acid within double-stranded DNA to produce 5' -phosphate and 3' -hydroxyl ends. RNase HII specifically recognizes an RNA base in a DNA double strand and breaks a phosphodiester bond connecting the DNA bases in the 5 '-direction of the RNA base, resulting in a nick of the DNA double strand in the 5' -direction of the RNA base. In organisms, DNA repair is initiated by the cleavage, RNA bases in double-stranded DNA can be removed, and the accuracy of genetic information is ensured. The invention designs a single-stranded probe based on the characteristic of RNase HII on strict pairing requirement of a substrate, wherein RNA base is embedded in the probe, and the RNase HII is applied to a report system of an amplification system. Since RNase HII recognizes and cleaves only double strands, it does not act on a single-stranded probe. Under a proper temperature, when the single-stranded DNA complementarily paired with the probe exists in the environment, the probe can be hybridized with the single-stranded DNA, the probe is cut off at a specific position by RNase HII, the melting temperature of the cut-off probe is reduced, the single-stranded DNA can not be stably combined with the complementary single-stranded DNA and can be dissociated, and the complementary single-stranded DNA can be combined with a new probe to start a new cycle, so that signal expansion is realized. In the whole process, the input of the single-stranded DNA complementary to the probe is converted into the output of the probe breakage through the cleavage of RNase HII, the specificity of the generated product is ensured through the complementary pairing principle of bases, meanwhile, the amplification of signals is realized, and the detection result is obtained through detecting the breakage condition of the probe.
In one aspect, useful primers and probes include those that hybridize to SEQ ID NO: 1-8 has a nucleotide sequence that is greater than 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identical. Such primer and probe modifications are also contemplated, as well as the introduction of base substitutions, and can be prepared according to standard techniques.
The term "base substitute" is a structure that contains no bases and that is attached upstream and downstream of a nucleic acid strand to maintain the integrity of the probe as a whole, nor does it interfere with hybridization of the nucleic acid strand. For example, when polymorphic sites that do not need to be detected are present in the target sequence, degenerate analysis can be achieved by substituting bases at positions corresponding to the probes with base substitutes. Base substitutes are commonly used as deoxynucleotide spacers (dSpacer) or C3 Spacer (Spacer). The number of base substitutes may be 1, 2, 3, 4, 5, 6.
The term "% identity" in the context of two or more nucleotide sequences or amino acid sequences refers to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection. For example,% identity is the entire length of the coding region relative to the sequences to be compared.
For sequence comparison, typically one sequence is used as a reference sequence, and the test sequence is compared to that sequence. When using a sequence comparison algorithm, the test sequence and reference sequence are input into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. The sequence comparison algorithm then calculates the percent sequence identity of the test sequence relative to the reference sequence based on the specified program parameters. The percent identity can be determined using search algorithms such as BLAST and PSI-BLAST (Altschul et al, 1990, J Mol Biol 215:3, 403-410; altschul et al, 1997, nucleic Acids Res25:17, 3389-402).
The primer and probe modification may be performed by a known method. Modified versions of these primer and/or probe sequences can include, by way of non-limiting example, adding one or more nucleotides to the 5 'end, one or more nucleotides to the 3' end, one or more nucleotides to the 5 'and 3' ends, adding tails, shortening the sequence, extending the sequence, shifting the sequence several bases upstream and downstream, or any combination thereof.
Base modifications such as 3'P, 5'P, 5-nitroindole, 2-aminopurine, 8-amino-2 ' -deoxyadenosine, C-5 propynyl-deoxycytidine, C-5 propynyl-deoxyuridine, 2-amino-2 ' -deoxyadenosine-5 ' -triphosphate, 2, 6-diaminopurine (2-amino-dA), inverted dT, inverted dideoxy-T, hydroxymethyl dC, iso-dC, 5-methyl dC, aminoethyl-phenoxazine-deoxycytidine, and locked nucleic acids (LNA's) and include at least one mismatched base at one of the bases, or at least one of the bases is replaced with an RNA base, to effect, for example, an increase in nucleic acid interactions at the 3' end of the mutant-specific primer to increase Tm. The modified probe should retain the ability to distinguish between the mutation site to be detected and the wild-type site.
Furthermore, with the exception of the specifically emphasized sites, the probes generally consist of DNA bases, as is generally understood by those skilled in the art. Similarly, the primer is composed of DNA bases.
In some embodiments, the RNA base of the probe corresponds to a SNP site base.
In some embodiments, the RNA base of the probe corresponds to the base adjacent to the SNP site.
In some embodiments, blocking of the 3 'end may also be achieved by adding a nucleic acid sequence to the 3' end of the probe that is unrelated to the target sequence.
In some embodiments, the arm modification is selected from any of ethylene glycol, C9 arm (Spacer 9), C18 arm (Spacer 18), dideoxy arm [1',2' -Dideoxyribose (dSpacer) ], C3 arm (C3 Spacer).
In some embodiments, the spacer modification is selected from the group consisting of a C3 spacer.
In some embodiments, the DNA bases of the probe on both sides of the ribonucleotide are labeled with a fluorescent group and a quenching group, respectively.
In some embodiments, the fluorophore of the probe is independently selected from any of AMCA, pacific Blue, atto 425, BODIPY FL, FAM, alexa Fluor 488, TET, JOE, yakima Yellow, VIC, HEX, quasar 570, cy3, NED, TAMRA, ROX, aqua phoor 593, texas Red, atto 590, cy5, quasar 670, cy5.5, and Cy 5.5.
In some embodiments, the quenching group of the probe is independently selected from any of BHQ1, BHQ2, BHQ3, dabcyl, eclipse, and MGB.
In some embodiments, the fluorescent groups with the same or similar excitation/emission wavelengths are labeled for different allelic forms of the probes, and different probes are respectively amplified and detected by a physical interval mode such as a branched pipe.
In some embodiments, different allelic probes are labeled with fluorescent groups of different excitation/emission wavelengths, and the different probes react in the same liquid system, distinguishing the genotype of the sample by the difference in fluorescent signals.
In some embodiments, the DNA bases of the probe on both sides of the ribonucleotide are each labeled with a molecule for interaction with a protein, said molecule being selected from any one of biotin, digoxin and FITC.
The invention also relates to a kit comprising the primer probe combination product.
The term "kit" refers to any article of manufacture (e.g., package or container) comprising at least one device, which may further comprise instructions, supplemental reagents, and/or components or assemblies for use in the methods described herein or steps thereof.
In some embodiments, the kit further comprises at least one of the following ingredients:
ribonuclease HII, sample lysate, control, reagents required by isothermal amplification reaction and immunochromatography detection card.
Depending on the reaction temperature, different RNase HII may be used. In some embodiments, the reaction temperature is 50℃to 70 ℃, preferably 55℃to 65 ℃, using a thermophilic, e.gThermus thermophilus、Pyrococcus abyssiRNase HII from source.
In some embodiments, the reagents required for the isothermal amplification reaction comprise at least one of the following components:
DNA polymerase, dNTPs and Mg with strand displacement capability 2+ 、Na + 、K + Buffer component, dithiothreitol.
In some embodiments, the DNA polymerase is Bst DNA polymerase.
The enzymes used in the present invention may be wild-type enzymes or mutant enzymes (typically with enhanced enzymatic activity or other preferred properties, such as better thermostability) that are sequence optimized.
The components are preferably realized in lyophilized form, for example in the form of one or more so-called lyophilized beads. Lyophilization beads are generally understood to mean lyophilisates which are pressed into spheres after manufacture, after which the substance is usually present as a powder. Thus, the components required for a isothermal reaction, in particular the DNA polymerase, the nucleic acid component and the reaction buffer component, can be provided, for example, in lyophilized form. In this way, the isothermal reaction process can be started directly in a very user-friendly manner by adding the sample to be quantified and optionally other desired components. In particular, the provision of a lyophilized form is very advantageous for automated applications. In some embodiments, the reagents required for the isothermal amplification reaction are lyophilized reagents.
In some embodiments, the reporter system of the immunochromatographic detection card is selected from any one of colloidal gold, latex, colloidal iron, labeled fluorescent molecules, and fluorescent quantum dots.
In some embodiments, a single immunochromatographic assay card detects for a single allele.
In some embodiments, a single immunochromatographic assay card detects for two or more allelic forms.
According to yet another aspect of the invention, the invention also relates to the use of a primer probe combination product as described above for the preparation of a diagnostic reagent or kit for detecting the ACTN3 genotype.
The invention also relates to the use of a primer probe combination product as described above, or a kit as described above, for detecting ACTN3 genotype.
In some embodiments, the temperature detected is 50 ℃ to 70 ℃, preferably 55 ℃ to 65 ℃, and optionally 60 ℃.
The temperature detected may be provided by a water bath.
In some embodiments, the time of detection is 10-60 minutes; for example 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes, 50 minutes; preferably 30 minutes.
Such use may be used to detect ACTN3 genotype.
The sample used to detect ACTN3 genotype is preferably an oral specimen (e.g., oral swab, etc.) of the subject, and the noninvasive sampling is effective in protecting the subject.
Embodiments of the present invention will be described in detail below with reference to examples.
Example 1 establishment of a method for detecting ACTN3 genotype by fluorescence method
And (3) performing conservation analysis on the sequence around the SNP locus rs1815739 of the ACTN3 gene, and performing primer and probe design aiming at rs 1815739. The primers and probes were designed as follows:
group A:
primer F3:5'-TGTTGCCTGTGGTAAGTGG-3' (SEQ ID NO: 1)
Primer B3:5'-GGGCTGAGGGTGATGTAGG-3' (SEQ ID NO: 2)
Primer FIP:5'-TGCCTTGAACTGATCGTGCGCGGGACACCAGCTGACACT-3' (SEQ ID NO: 3)
Primer BIP:5'-CCATCATGGGCATCCAGGGTATTGGTGGAGCAGGGCC-3' (SEQ ID NO: 4)
Primer LF:5'-AGGCTCTGGGGACGACA-3' (SEQ ID NO: 5)
Primer LB:5'-GAGATCCAGAAGATCTGCCAGA-3' (SEQ ID NO: 6)
Primer probe C:5'-CGCTC [ dT-BHQ1] C [ rG ] GT [ dC-FAM ] AGCC-3' (SEQ ID NO: 7)
Primer probe T:5'-TCGCTC [ dT-BHQ1] C [ rA ] GT [ dC-FAM ] AGCCT-3' (SEQ ID NO: 8)
Primer probe C (17 base): 5'-TCGCTC [ dT-BHQ1] C [ rG ] GT [ dC-FAM ] AGCCT-3'
Primer probe C (13 base): 5'-GCTC [ dT-BHQ1] C [ rG ] GT [ dC-FAM ] AGC-3'
Primer probe T (19 base): 5'-CTCGCTC [ dT-BHQ1] C [ rA ] GT [ dC-FAM ] AGCCTC-3'
Primer probe T (15 base): 5'-CGCTC [ dT-BHQ1] C [ rA ] GT [ dC-FAM ] AGCC-3 ]'
The primer group is matched with probes with different lengths, and respectively carries out the amplification of C, T allelic plasmids and blank (NF-H 2 O) detecting.
The results are shown in FIG. 1. The different probes have no non-specific reaction to the blank group detection. For probes of different lengths, long probes will result in reduced allelic discrimination and short probes will have lower positive signals. In the subsequent examples of the present invention, the reaction system was prepared using primers and a medium-length probe (C-15 base, T-17 base).
Establishment of detection method
The invention constructs a kit for detecting ACTN3 genotype based on a isothermal amplification system and a ribonuclease HII report system, which comprises a sample lysate, the isothermal amplification system and a ribonuclease HII report system reaction module, wherein the sample lysate contains a Tris-HCL buffer system, naOH, SDS, EDTA, guanidine isothiocyanate, tween80 and triton; the optimal allocation ratio of the reaction system in the reaction module of the isothermal amplification system and ribonuclease HII report system is shown in table 1, and the optimal allocation ratio comprises the fluorescent labeled probe and the primer; the control was a plasmid containing the ACTN3 target gene, and the C, T control nucleotides at position rs1815739 were C and T, respectively.
TABLE 1 reaction System ratio of reaction modules
Sequence number | Component (A) | Concentration of |
1 | Tris-HCl(pH 8.8) | 20 mM |
2 | Ammonium sulfate | 10 mM |
3 | Potassium chloride | 50 mM |
4 | Magnesium sulfate | 2 mM |
5 | Tween 20 | 0.10% |
6 | Group A primer F3 | 0.2 μM |
7 | Group A primer B3 | 0.2 μM |
8 | Group A primer FIP | 1.6 μM |
9 | Group A primer BIP | 1.6 μM |
10 | Group A primer LF | 0.4 μM |
11 | Group A primer LB | 0.4 μM |
12 | Group A primer probe | 0.1 μM |
13 | Bst polymerase | 16 U |
The reaction conditions of the reaction system are as follows: reacting for 10-60min at 50-65 ℃.
The optimal reaction conditions are as follows: the reaction was carried out at 63℃for 30min.
The detection flow of the kit is as follows:
step one, sample processing. Shaking and uniformly mixing 15 mu L of sample lysate and 10 mu L C control/T control/sample to be detected, and standing at room temperature for 5 min;
step two, adding all the products of the step one into a reaction module of a constant-temperature amplification system and a ribonuclease HII report system, covering a tube cover, vibrating and centrifuging, and immediately detecting; the reaction procedure is: the fluorescent signal is collected at 63 ℃ for 1 minute and 30 cycles, and the detection can be completed within 30 minutes;
and step three, judging the result.
(1) C control: the typical amplification curve appears in the probe system C, and the fluorescence value of the end point is higher than or equal to the fluorescence value of the starting point by more than 3 times; no amplification curve appears in the T probe system, or the end point fluorescence value is 3 times lower than the starting point fluorescence value; the two points are met as effective results;
(2) t control: typical amplification curves appear in the T probe system, and the fluorescence value of the end point is higher than or equal to that of the starting point by more than 3 times; no amplification curve appears in the probe system, or the end point fluorescence value is 3 times lower than the starting point fluorescence value; the two points are met as effective results;
(3) the sample to be tested:
a. if the end point fluorescence value in the single probe system is more than or equal to 3 times of the start point fluorescence value, judging that the single probe system is homozygote of the same type;
b. if the end point fluorescence values in the two probe systems are higher than or equal to the start point fluorescence value by more than 3 times, judging the two probe systems as heterozygotes;
c. if the end point fluorescence values in the two probe systems are lower than 3 times of the starting point fluorescence values, judging that the two probe systems are abnormal, and re-detecting or re-sampling and detecting.
Example 2 analysis of real samples by ACTN3 genotyping fluorescence detection kit
The detection effect of the kit on the real sample was examined by using 4 cases of oral swabs (CC type 1 case, TT type 1 case, CT type 2 case) with known genotypes.
The specific operation is as follows:
4 cases of oral swabs were taken and tested against C, T, and the results were recorded.
The results are shown in FIG. 2. C. The T control detection result is normal. The detection results of the 4 samples are identical to the known genotypes. The kit is shown to be accurate and effective in detecting a real oral swab sample.
Example 3 stability test of ACTN3 genotype fluorescence detection kit
The liquid reagent needs to be stored at low temperature and can not be repeatedly frozen and thawed. The kit is characterized in that a fluorescent reaction module comprising a constant-temperature amplification system and a ribonuclease HII reporting system is dried into a powdery reagent in vacuum, the freeze-dried powdery reagent can be stored at normal temperature, the cost of cold chain transportation and low-temperature storage is saved, and the operation is simpler. The stability of the ACTN3 genotype fluorescence detection kit was verified in this example.
The specific operation is as follows:
eight-tube containing lyophilized reagents were sealed in aluminum foil bags containing a desiccant and stored in a 37 ℃ incubator. Freeze-dried reagents were taken and tested at 0 day, 30 day, 90 day, 180 day, respectively.
Taking C control and T control for detection respectively, and recording the results.
The results are shown in FIG. 3. The reagent freeze-dried powder of the reaction module stored for 0 day, 30 days, 90 days and 180 days is tested respectively, and the detection results of the reagent in the kit of the invention after freeze-drying are all in line with each other in 0 day, 30 days, 90 days and 180 days. The reagent in the kit of the invention can be stably stored for at least 3 months at 37 ℃ after freeze-drying.
Example 4 establishment of a method for detecting ACTN3 genotyping colloidal gold assay kit
Compared with detection equipment for judging through fluorescence, the immunochromatography card with the color change judging through naked eyes, such as colloidal gold, latex and the like, omits a module for fluorescence excitation and reading, has lower cost and is more suitable for a detection scene outside a laboratory.
In the embodiment, a detection kit using a colloidal gold immunochromatographic card as a reporting system is constructed.
The kit configuration of this example was substantially identical to that of example 1, except that: (1) The probe modification is adjusted from fluorescent labeling to labeling that can be recognized by an immunochromatographic card; (2) Based on the composition of the kit in the example 1, a colloidal gold immunochromatographic card for detecting an amplification product is added.
Probe sequences used in this example:
primer probe C:5 '-biotin-CGCTCTCTC [ rG ] GTCAGCC-digoxin-3' (SEQ ID NO: 7)
Primer probe T:5'-biotin-TCGCTCTC [ rA ] GTCAGCCT-digoxin-3' (SEQ ID NO: 8)
The colloidal gold immunochromatographic card used was divided into 3 regions: sample pad, NC membrane, absorbent pad.
The sample pad contains nano gold particles marked with digoxin antibody. The NC is respectively provided with a quality control line (C line) and a detection line (T line) in sequence, the C line is fixed with streptavidin, and the T line is fixed with a goat anti-mouse secondary antibody, so that the digoxin antibody of the gold standard can be identified.
When no allelic form consistent with the probe exists in the sample, the probe remains intact, a gold labeled digoxin antibody-probe-streptavidin complex is formed, all the nano gold particles are captured by the C line, the C line develops color, and the T line does not develop color. When the allelic form consistent with the probe exists in the sample, the probe is partially/completely cut off, the formation of the gold labeled digoxin antibody-probe-streptavidin complex is reduced or impossible, the nano gold particles cannot be completely captured by the C line, the nano gold particles which cannot be captured continue to flow and then are captured by the T line, the C line is colored or not colored, and the T line is colored.
The detection flow is as follows:
step one, sample processing. Shaking and uniformly mixing 30 mu L of sample lysate and 20 mu L of control/sample to be detected, and standing at room temperature for 5 min;
step two, adding 25 mu L of the product obtained in the step one into a C, T reaction module, covering a tube cover, vibrating and centrifuging, and immediately reacting; the reaction procedure is: 30 minutes at 63 ℃;
step three, respectively adding the products of each tube of the step two to sample pads of different colloidal gold chromatographic cards, waiting for 5 min, and observing the results;
and step three, judging the result.
(1) C control: c, detecting card of system loading: developing by a T line; t system sample detection card: the color of the C line is developed, and the T line is not developed;
(2) t control: c, detecting card of system loading: the color of the C line is developed, and the T line is not developed; t system sample detection card: developing by a T line;
(3) the sample to be tested:
a. if the T line of the detection card of the single probe system is developed, judging that the single probe system is homozygote of the allelic type;
b. if the T lines of the detection cards of the two probe systems are developed, judging that the two probe systems are heterozygotes;
c. if the C, T line in any system does not develop color, or the T line in both systems does not develop color, judging that the system is abnormal, and re-detecting or re-sampling and detecting.
The detection results are shown in figure 4, and the detection results of the colloidal gold immunochromatographic card are identical with the known genotypes. Indicating the validity of the system.
The technical features of the above-described embodiments may be arbitrarily combined, and all possible combinations of the technical features in the above-described embodiments are not described for brevity of description, however, as long as there is no contradiction between the combinations of the technical features, they should be considered as the scope of the description.
The above examples illustrate only a few embodiments of the invention, which are described in detail and are not to be construed as limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention. Accordingly, the scope of protection of the present invention is to be determined by the appended claims.
SEQUENCE LISTING
<110>
<120>ACTN3
<130> 113201593
<160> 8
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213>
<400> 1
tgttgcctgt ggtaagtgg 19
<210> 2
<211> 19
<212> DNA
<213>
<400> 2
gggctgaggg tgatgtagg 19
<210> 3
<211> 39
<212> DNA
<213>
<400> 3
tgccttgaac tgatcgtgcg cgggacacca gctgacact 39
<210> 4
<211> 37
<212> DNA
<213>
<400> 4
ccatcatggg catccagggt attggtggag cagggcc 37
<210> 5
<211> 17
<212> DNA
<213>
<400> 5
aggctctggg gacgaca 17
<210> 6
<211> 22
<212> DNA
<213>
<400> 6
gagatccaga agatctgcca ga 22
<210> 7
<211> 15
<212> DNA
<213>
<400> 7
cgctctcggt cagcc 15
<210> 8
<211> 17
<212> DNA
<213>
<400> 8
tcgctctcag tcagcct 17
Claims (1)
1. The kit for detecting the rs1815739 site nucleotide of the ACTN3 gene comprises a primer probe combination product, a sample lysate, a control, a constant-temperature amplification system and a ribonuclease HII report system reaction module;
the primer probe combination product comprises an outer primer pair consisting of F3 and B3, an inner primer pair consisting of FIP and BIP, and a loop primer and a probe;
the nucleotide sequences of F3, B3, FIP and BIP are shown in SEQ ID NO: 1-4;
the nucleotide sequence of the loop primer is shown as SEQ ID NO: 5-6;
the nucleotide sequence of the probe is shown as SEQ ID NO: 7-8, wherein 8 th and 9 th nucleotides of the 5' ends of the two probes are ribonucleotides;
the sample lysate contains a Tris-HCL buffer system, naOH, SDS, EDTA, guanidine isothiocyanate, tween80 and triton;
the reagent required by the isothermal amplification reaction comprises the following components: ribonuclease HII, bst DNA polymerase, dNTPs, mg 2+ 、Na + 、K + Buffer component, dithiothreitol;
the isothermal amplification system and a fluorescence reaction module of the ribonuclease HII report system are dried into powdery reagents in vacuum;
the reaction system of the reaction module comprises the following components:
。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110568459.1A CN113201593B (en) | 2021-05-25 | 2021-05-25 | Primer probe combination product for detecting ACTN3 genotype |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110568459.1A CN113201593B (en) | 2021-05-25 | 2021-05-25 | Primer probe combination product for detecting ACTN3 genotype |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113201593A CN113201593A (en) | 2021-08-03 |
CN113201593B true CN113201593B (en) | 2024-01-23 |
Family
ID=77023122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110568459.1A Active CN113201593B (en) | 2021-05-25 | 2021-05-25 | Primer probe combination product for detecting ACTN3 genotype |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113201593B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212615A (en) * | 2011-04-01 | 2011-10-12 | 上海交通大学 | Method for detecting single-nucleotide polymorphism based on high-temperature resistant RNase HII |
CN103571932A (en) * | 2012-07-25 | 2014-02-12 | 上海赛弗生物科技有限公司 | Detection method for single nucleotide polymorphism based on heat-resistant nuclease HII |
CN106148549A (en) * | 2016-08-31 | 2016-11-23 | 湖南大学 | A kind of loop-mediated isothermal amplification technique based on connection is for detection method of gene mutation |
CN106715720A (en) * | 2014-08-11 | 2017-05-24 | 卢米耐克斯公司 | Probes for improved melt discrimination and multiplexing in nucleic acids assays |
CN107447031A (en) * | 2017-09-18 | 2017-12-08 | 湖南融健基因生物科技有限公司 | The mutant nucleic acid Russian Market of ring mediated isothermal amplification is carried out in a kind of emulsion |
CN107937486A (en) * | 2017-12-25 | 2018-04-20 | 苏州旷世骏弛生物科技有限公司 | A kind of method for detecting single nucleotide polymorphism based on heat stable nuclease HII |
CN108431235A (en) * | 2015-12-22 | 2018-08-21 | 索灵股份公司 | The method of the fluoroscopic examination of the isothermal loop mediated amplification (LAMP) of target nucleic acid, oligonucleotides and its kit |
US10468141B1 (en) * | 2018-11-28 | 2019-11-05 | Asia Genomics Pte. Ltd. | Ancestry-specific genetic risk scores |
CN110878368A (en) * | 2019-12-05 | 2020-03-13 | 华南农业大学 | Novel LAMP method, primer group and kit capable of detecting SNP |
CN111073958A (en) * | 2019-12-24 | 2020-04-28 | 河北省体育科学研究所 | Primer probe combination, kit and application of primer probe combination and kit in detection of ACTN3 gene mutation |
CN111705150A (en) * | 2020-08-19 | 2020-09-25 | 中南大学湘雅医院 | Method, primer and kit for detecting clostridium difficile ribosome 027 type virulence regulatory gene tcdC |
-
2021
- 2021-05-25 CN CN202110568459.1A patent/CN113201593B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212615A (en) * | 2011-04-01 | 2011-10-12 | 上海交通大学 | Method for detecting single-nucleotide polymorphism based on high-temperature resistant RNase HII |
CN103571932A (en) * | 2012-07-25 | 2014-02-12 | 上海赛弗生物科技有限公司 | Detection method for single nucleotide polymorphism based on heat-resistant nuclease HII |
CN106715720A (en) * | 2014-08-11 | 2017-05-24 | 卢米耐克斯公司 | Probes for improved melt discrimination and multiplexing in nucleic acids assays |
CN108431235A (en) * | 2015-12-22 | 2018-08-21 | 索灵股份公司 | The method of the fluoroscopic examination of the isothermal loop mediated amplification (LAMP) of target nucleic acid, oligonucleotides and its kit |
CN106148549A (en) * | 2016-08-31 | 2016-11-23 | 湖南大学 | A kind of loop-mediated isothermal amplification technique based on connection is for detection method of gene mutation |
CN107447031A (en) * | 2017-09-18 | 2017-12-08 | 湖南融健基因生物科技有限公司 | The mutant nucleic acid Russian Market of ring mediated isothermal amplification is carried out in a kind of emulsion |
CN107937486A (en) * | 2017-12-25 | 2018-04-20 | 苏州旷世骏弛生物科技有限公司 | A kind of method for detecting single nucleotide polymorphism based on heat stable nuclease HII |
US10468141B1 (en) * | 2018-11-28 | 2019-11-05 | Asia Genomics Pte. Ltd. | Ancestry-specific genetic risk scores |
CN110878368A (en) * | 2019-12-05 | 2020-03-13 | 华南农业大学 | Novel LAMP method, primer group and kit capable of detecting SNP |
CN111073958A (en) * | 2019-12-24 | 2020-04-28 | 河北省体育科学研究所 | Primer probe combination, kit and application of primer probe combination and kit in detection of ACTN3 gene mutation |
CN111705150A (en) * | 2020-08-19 | 2020-09-25 | 中南大学湘雅医院 | Method, primer and kit for detecting clostridium difficile ribosome 027 type virulence regulatory gene tcdC |
Non-Patent Citations (2)
Title |
---|
Zhang Q 等.ACTN3 is associated with children's physical fitness in Han Chinese..Mol Genet Genomics..2019,第294卷(第1期),第47-56页. * |
环介导等温扩增技术在单核苷酸多态性检测中的应用;李森 等;化学与生物工程;第34卷(第03期);第1-6页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113201593A (en) | 2021-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102085119B1 (en) | Detection of nucleic acids | |
CN116064748A (en) | Method for variant detection | |
JP4891985B2 (en) | Development of real-time PCR assay for pneumococcal DNA detection and diagnosis of pneumococcal disease | |
US20060252064A1 (en) | Polynucleotide primers and probes for rapid detection of group B streptococcus (GBS) | |
JP2002536981A (en) | Method for measuring the presence of a nucleic acid target sequence and its application | |
JP7175326B2 (en) | Target nucleic acid amplification method and target nucleic acid amplification composition | |
CN112961943A (en) | Primer probe combination product for detecting SARS-CoV-2 | |
WO2013128397A1 (en) | Real-time pcr detection of streptococcus pyogenes | |
US20120045747A1 (en) | Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using the same | |
KR102030244B1 (en) | Oligonucleotide set for detection of dengue virus and uses thereof | |
JP7045702B2 (en) | Single-stranded nucleic acid for detecting nucleic acid in real time and detection method using this | |
CN113073152A (en) | LAMP primer, probe and kit for detecting influenza B virus | |
JP2018007694A (en) | Dual probe assay for detection of target nucleic acid | |
EP4118205A1 (en) | Looped primer and loop-de-loop method for detecting target nucleic acid | |
CN108060213A (en) | Isothermal duplication method detection SNP site probe and kit based on the recombinase-mediated that probe is oriented to | |
CN109863252A (en) | For detecting or quantifying the composition and method of Hepatitis C Virus | |
CN113201593B (en) | Primer probe combination product for detecting ACTN3 genotype | |
CN105705660B (en) | Detection of single nucleotide polymorphisms using overlapping primers and melting probes | |
US11814689B2 (en) | Nucleic acid detection using type III CRISPR complex | |
JP2008537676A (en) | Nucleic acid detection | |
WO2013128405A1 (en) | Real time pcr detection of respiratory syncytial virus | |
KR102030245B1 (en) | Oligonucleotide set for detection of chikungunya virus and uses thereof | |
McChlery et al. | The use of hydrolysis and hairpin probes in real-time PCR | |
CN113106089A (en) | Isothermal amplification kit of primer probe combination for detecting influenza A | |
CN111073958A (en) | Primer probe combination, kit and application of primer probe combination and kit in detection of ACTN3 gene mutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210727 Address after: 510010 room 2007, No. 563, Shougouling, Tianhe District, Guangzhou, Guangdong Applicant after: Guangzhou Shengshi Zhonghao Sports Technology Co.,Ltd. Address before: 510000 room 402, No.6 lianhuayan Road, Huangpu District, Guangzhou City, Guangdong Province Applicant before: Guangzhou universal Junan Biotechnology Co.,Ltd. Applicant before: Guangzhou Shengshi Zhonghao Sports Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |